| 12460001 |
Proteins comprising CD3 antigen binding domains and uses thereof |
Raymond Brittingham, Scott Ronald Brodeur, Rajkumar Ganesan, James R. Hoover, Colleen Kane +7 more |
2025-11-04 |
|
| 12304939 |
EGFR and C-met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Alastair King +4 more |
2025-05-20 |
|
| 12291797 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Karyn O'Neil |
2025-05-06 |
|
| 12258385 |
CD137 binding fibronectin type III domains |
Michael Diem, Rebecca Hawkins, Manuel Sepulveda |
2025-03-25 |
|
| 12202732 |
Aqueous hydrophobic silica dispersions |
Lang H. Nguyen, Kavita K. Pai, Tianqi Liu, Melissa J. Monello, Angelica M. Sanchez Garcia +2 more |
2025-01-21 |
|
| 12054534 |
Prostate specific membrane antigen binding fibronectin type iii domains |
Rosa Cardoso, Michael Diem, Shalom Goldberg, Linus Hyun, Donna Klein +2 more |
2024-08-06 |
$410,876,000 |
| 11987501 |
Aqueous hydrophobic silica dispersions |
Lang H. Nguyen, Kavita K. Pai, Tianqi Liu, Melissa J. Monello, Angelica M. Sanchez Garcia +2 more |
2024-05-21 |
$32,550,000 |
| 11932680 |
CD8A-binding fibronectin type III domains |
Rebecca Hawkins, Manuel Sepulveda |
2024-03-19 |
$305,105,000 |
| 11833190 |
Serum albumin-binding fibronectin type III domains |
Michael Diem, Karyn O'Neil, Thomas J. Rutkoski |
2023-12-05 |
$229,667,000 |
| 11702475 |
Cysteine engineered fibronectin type III domain binding molecules |
Shalom Goldberg, Tricia Lin, Karyn O'Neil |
2023-07-18 |
$328,585,000 |
| 11479880 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Karyn O'Neil |
2022-10-25 |
$370,166,000 |
| 11447539 |
PD-L1 binding fibronectin type III domains |
Michael Diem, Rebecca Hawkins, Manuel Sepulveda |
2022-09-20 |
$224,601,000 |
| 11345739 |
CD137 binding fibronectin type III domains |
Michael Diem, Rebecca Hawkins, Manuel Sepulveda |
2022-05-31 |
$560,355,000 |
| 11299534 |
CD8A-binding fibronectin type III domains |
Rebecca Hawkins, Manuel Sepulveda |
2022-04-12 |
$449,035,000 |
| 11072663 |
Cysteine engineered fibronectin type III domain binding molecules |
Shalom Goldberg, Tricia Lin, Karyn O'Neil |
2021-07-27 |
$445,875,000 |
| 10954284 |
EGFR and c-Met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Alastair King +4 more |
2021-03-23 |
$120,756,000 |
| 10925932 |
Serum albumin-binding fibronectin type III domains |
Michael Diem, Karyn O'Neil, Thomas J. Rutkoski |
2021-02-23 |
$143,700,000 |
| 10844122 |
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof |
Glenn Mark Anderson, Rosa Cardoso, Michael Diem, Francois Gaudet, Shalom Goldberg +15 more |
2020-11-24 |
$91,850,000 |
| 10844111 |
Prostate specific membrane antigen binding fibronectin type III domains |
Rosa Cardoso, Michael Diem, Shalom Goldberg, Linus Hyun, Donna Klein +2 more |
2020-11-24 |
$91,850,000 |
| 10662235 |
Cysteine engineered fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Alastair King +5 more |
2020-05-26 |
$121,919,000 |
| 10654913 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Karyn O'Neil |
2020-05-19 |
$146,179,000 |
| 10626165 |
CD8a-binding fibronectin type III domains |
Rebecca Hawkins, Manuel Sepulveda |
2020-04-21 |
$141,871,000 |
| 10611823 |
CD137 binding fibronectin type III domains |
Michael Diem, Rebecca Hawkins, Manuel Sepulveda |
2020-04-07 |
|
| 10597438 |
PD-L1 binding fibronectin type III domains |
Michael Diem, Rebecca Hawkins, Manuel Sepulveda |
2020-03-24 |
$87,168,000 |
| 10571472 |
Fibronectin type III repeat based protein scaffolds with alternative binding surfaces |
Michael Diem |
2020-02-25 |
$73,835,000 |
